Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
Vedolizumab
Genes
Gene expression
MORTALITY
Small molecules
Immune cells
Microbiota
Methylation
Gènes
Maintenance therapy
Intestinal crypts
Therapeutics
Ulcerative colitis
Clinical guidelines
Venous thromboembolism
Disease Progression
Inclusion
Original Article Clinical
Drug
Resistance
Patients experience
Patient-reported outcome
T1118 translocation
Algorithm
Dysbiose
Upper gastrointestinal tract
Acceptability
DNA methylation
Contraindication
Colon cancer
Neoadjuvant chemotherapy
Colorectal cancer Colibactin and lipids
IL12
Rituximab plus chlorambucil
Alkylating agents
HIV
Fecal microbiota
Rituximab
Epigenetics
Colorectal cancer
18 FDG-PET/CT
Anti-TNF agents
Clinical trial
Heart disease risk factors
Eradication
Colon
Cost effectiveness
Résistance
Effectiveness
Inflammatory bowel diseases
Parvimonas micra
Over 80s
Crohn's disease
Inflammatory Bowel Diseases
Monitoring
Immunosuppressant
Thérapie ciblée
Crohn’s disease
CARCINOGENESIS
Eligibility
Ustekinumab
IBD
Cancer
RISK
Inflammatory bowel disease
Stricture
Anti-TNF
Colectomy
Dysbiosis
Biomarker
COLON-CANCER
Kidney diseases
MICROBIOTA
Primary sclerosing cholangitis
Microbiote
Tuberculosis
Survival
Helicobacter pylori
Disease progression
Tailored therapy
Endoscopic treatment
Consensus
Epigénétiques
Safety
Gene methylation
Méthylation
Disability
Surgery
Bactéries
Cell adhesion
PCR
Colonic epithelial primary cells
MARKER
IL23
MALT
Biologics
Inhibitor
DNA METHYLATION
Bacteria
Screening
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|